Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,369.10INR
15 Dec 2017
Change (% chg)

Rs-29.50 (-1.23%)
Prev Close
Rs2,398.60
Open
Rs2,391.30
Day's High
Rs2,415.00
Day's Low
Rs2,351.05
Volume
20,541
Avg. Vol
9,292
52-wk High
Rs2,798.50
52-wk Low
Rs2,201.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 2 2
(3) HOLD 2 3 3 3
(4) UNDERPERFORM 6 6 5 5
(5) SELL 1 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.42 3.25 3.30 3.30

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 1 7,292.00 7,292.00 7,292.00 --
Quarter Ending Mar-18 1 10,413.00 10,413.00 10,413.00 --
Year Ending Mar-17 9 29,429.40 31,443.30 28,000.00 --
Year Ending Mar-18 9 31,860.60 33,893.00 29,680.00 35,059.80
Year Ending Mar-19 9 35,858.90 39,101.00 33,240.00 37,297.80
Earnings (per share)
Year Ending Mar-17 8 38.34 49.50 32.00 --
Year Ending Mar-18 9 42.61 46.00 37.49 64.72
Year Ending Mar-19 9 52.17 63.40 40.29 54.62

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 7,292.00 -- -- -- --
Quarter Ending Mar-18 10,413.00 10,413.00 10,413.00 10,413.00 --
Year Ending Mar-17 29,429.40 -- -- -- --
Year Ending Mar-18 31,860.60 31,860.60 32,305.90 32,572.70 35,059.80
Year Ending Mar-19 35,858.90 35,858.90 36,260.00 36,308.60 37,297.80
Earnings (per share)
Year Ending Mar-17 38.34 -- -- -- --
Year Ending Mar-18 42.61 42.61 43.53 43.20 64.72
Year Ending Mar-19 52.17 52.17 53.25 52.19 54.62

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 -- -- -- --
Quarter Ending Mar-18 0 0 0 0
Year Ending Mar-17 -- -- -- --
Year Ending Mar-18 0 0 0 2
Year Ending Mar-19 0 0 0 1
Earnings
Year Ending Mar-17 -- -- -- --
Year Ending Mar-18 0 0 0 1
Year Ending Mar-19 0 0 0 1